Research never stops

Top Story

Evotec awarded grant from The Michael J. Fox Foundation for Parkinson's Research

Hamburg, Germany - 02 February 2016: Evotec AG today announced that it has been awarded a research grant from The Michael J. Fox Foundation to further develop Evotec's TargetaSN (Targetalpha-synuclein) programme for the treatment of Parkinson's disease.

- read more

Evotec achieves important milestone in TargetAD collaboration with Janssen in Alzheimer's disease

Hamburg, Germany - 12 January 2016: Evotec AG today announced the achievement of an important milestone in its TargetAD collaboration with Janssen Pharmaceuticals, Inc. for the transition of a project into further drug discovery process.

- read more

Evotec and UCB sign multi-year sample management agreement

Hamburg, Germany - 07 January 2016: Evotec AG today announced an EVT Execute collaboration aimed at providing a complete solution to UCB's global sample management requirements.

 

Watch a short video clip on this press release

- read more
loading weather report
Loading weather report...

Events

Mar 09, 2016 - 2016 BD Boston

Feb 17, 2016 - ODDO SEYDLER Small & Mid Cap Conference

Company Presentation February

Building integrated and high-value drug discovery alliances
2016-02_Evotec_Company presentation_February